Arthropathy Shoulder Clinical Trial
Official title:
The Effect of Tranexamic Acid on Calculated Total Blood Loss in Patients Undergoing Revision Shoulder Arthroplasty
This is a phase IV, randomized, single-blind, single-center study comparing calculated total blood loss, surgical drain output and hematoma formation in patients who receive 2 doses of Tranexamic Acid (TXA) versus control group undergoing revision total shoulder arthroplasty. Patients will be randomized to either receive 2 doses of IV TXA, first dose prior to surgical incision and second dose given 3 hours later or to the control group, where no TXA will be administered.
The objectives of the study are to compare the effectiveness of IV TXA on reducing calculated total blood loss, surgical drain output and hematoma formation in patients undergoing revision total shoulder arthroplasty. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03663283 -
Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty
|
Phase 4 | |
| Not yet recruiting |
NCT04449146 -
Scapular Positioning in Standing Position Using Sonography
|
N/A | |
| Active, not recruiting |
NCT03727490 -
The Role of Subscapularis Repair in Reverse Shoulder Arthroplasty
|
N/A | |
| Withdrawn |
NCT05341518 -
Subscapularis Repair During Reverse Total Shoulder Arthroplasty
|
N/A | |
| Completed |
NCT03735173 -
Comparing the Outcome of Cemented All-Polyethylene Pegged vs. Keeled Components Through a Subscapularis Tenotomy or a Subscapularis Peel
|
N/A | |
| Active, not recruiting |
NCT05499728 -
Telerehabilitation After Shoulder Arthroplasty
|
N/A | |
| Terminated |
NCT03599336 -
RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures
|
N/A |